These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6966203)

  • 1. Stimulation of tumor-specific cytotoxic T-lymphocyte responses in vitro by hapten-reactive helper T lymphocytes and the allogeneic effect.
    Altman A; Katz DH
    Clin Immunol Immunopathol; 1980 Mar; 15(3):552-64. PubMed ID: 6966203
    [No Abstract]   [Full Text] [Related]  

  • 2. Manipulation of cytotoxic T lymphocyte responses to syngeneic tumors. I. Hapten-reactive helper T lymphocytes augment tumor-specific CTL responses in vitro.
    Altman A; Bechtold TE; Katz DH
    J Immunol; 1979 Jun; 122(6):2484-90. PubMed ID: 87464
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
    Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro.
    Yamashita U; Hamaoka T
    J Immunol; 1979 Dec; 123(6):2637-43. PubMed ID: 315427
    [No Abstract]   [Full Text] [Related]  

  • 6. Unresponsiveness in hapten-specific cytotoxic lymphocytes. II. Ability of various TNP-congeners to induce unresponsiveness after repeated treatments beginning at birth.
    Butler LD; Miller SD; Claman HN
    J Immunol; 1982 May; 128(5):1963-7. PubMed ID: 6977577
    [No Abstract]   [Full Text] [Related]  

  • 7. Helper cell analysis in cytotoxic T lymphocyte responses. I. Activation of specific and cross-reactive helper effects in two hapten-modified self responses.
    Levy RB; Fujiwara H; Shearer GM
    Eur J Immunol; 1980 Dec; 10(12):904-7. PubMed ID: 6162647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes.
    Sherman L; Mescher MF; Burakoff SJ
    J Immunol; 1979 Jul; 123(1):501-2. PubMed ID: 312884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
    J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
    Arora PK; Shearer GM
    J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of hapten-conjugated isologous mouse gamma-globulin as a tolerogen on H-2 restricted cytotoxic effector cells.
    Waksal SD; Borel Y
    J Immunol; 1980 Mar; 124(3):1506-9. PubMed ID: 6153687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular requirements for trinitrophenyl recognition by antihapten cytotoxic T lymphocytes.
    Hale AH
    Cell Immunol; 1980 Feb; 49(2):408-14. PubMed ID: 6243516
    [No Abstract]   [Full Text] [Related]  

  • 14. Hapten-reactive inducer T cells. I. Definition of two classes of hapten-specific inducer cells.
    Clayberger C; Dekruyff RH; Aisenberg J; Cantor H
    J Exp Med; 1983 Jun; 157(6):1906-19. PubMed ID: 6602202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of T-cell function: alloreactivity appears earlier than reactivity against hapten-modified self and interleukin-2 production.
    Stutman O; Ishizaka ST
    Clin Immunol Immunopathol; 1982 May; 23(2):202-14. PubMed ID: 6213338
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
    Moser G; Burakoff SJ; Abbas AK
    J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activational signals for immune effector and suppressor T cells reactive with haptenic determinants.
    Tominaga A; Bromberg JS; Takaoki M; Lefort S; Noseworthy J; Benacerraf B; Greene MI
    Ann N Y Acad Sci; 1982; 392():309-17. PubMed ID: 6215883
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo generation and regulation of killer T-cells directed towards hapten-coupled syngeneic cells.
    Butler LD; Battisto JR
    Ann N Y Acad Sci; 1979; 332():524-30. PubMed ID: 316985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.